Browsing "1. College of Medicine (의과대학)" by Author : 2481

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 121 to 180 of 568

This table browses all dspace content
Issue DateTitleJournal Title
2014Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean populationLIVER INTERNATIONAL
2021Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapyHEPATOLOGY INTERNATIONAL
2011Controversies in surveillance and early diagnosis of hepatocellular carcinomaONCOLOGY
2017Conventional versus drug-eluting beads chemoembolization for hepatocellular carcinoma: Emphasis on the impact of tumor sizeJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2010Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg.JOURNAL OF CLINICAL PATHOLOGY
2020Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2021Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2022Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mLHEPATOLOGY INTERNATIONAL
2018Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety GUT AND LIVER
2017Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2012Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccineVACCINE
2020Design and Validation of Risk Prediction Model for Hepatocellular Carcinoma Development After Sustained Virological Response in Patients With Chronic Hepatitis CEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2021Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaireRESEARCH IN NURSING & HEALTH
2021Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2019Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation Cancer Medicine
2019Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Cancers
2016Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background BMC GASTROENTEROLOGY
2023Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patientsINTERNATIONAL JOURNAL OF CANCER
2017Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway ONCOTARGET
2021Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma AMERICAN JOURNAL OF CANCER RESEARCH
2021Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyDIGESTIVE DISEASES AND SCIENCES
2020Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyGUT
2013Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B PLOS ONE
2015Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosisCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2014Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen JOURNAL OF VIROLOGY
2017Durability of the virological response after lamivudine discontinuation in lamivudine-resistant patients with a complete virological response after lamivudine and adefovir combination therapyJOURNAL OF MEDICAL VIROLOGY
2021Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis BEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2014Dynamics of the Liver Stiffness Value Using Transient Elastography during the Perioperative Period in Patients with Valvular Heart Disease PLOS ONE
2013Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapyLIVER INTERNATIONAL
2012Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2013Early Predictor of Mortality due to Irreversible Posthepatectomy Liver Failure in Patients with Hepatocellular CarcinomaWORLD JOURNAL OF SURGERY
2011Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinomaLIVER INTERNATIONAL
2022Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICS
2022Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide studyHEPATOLOGY RESEARCH
2017Effect of S267F variant of NTCP on the patients with chronic hepatitis B SCIENTIFIC REPORTS
2021Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2017Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis GUT AND LIVER
2022Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of LobeglitazoneCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT
2006Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea YONSEI MEDICAL JOURNAL
2019Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study CLINICAL AND MOLECULAR HEPATOLOGY
2020Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 TrialINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2023Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study KOREAN JOURNAL OF INTERNAL MEDICINE
2009Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resectionAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2010Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.JOURNAL OF MEDICAL VIROLOGY
2021Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patientsHEPATOLOGY INTERNATIONAL
2020Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus InfectionCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2013Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma PLOS ONE
2016Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study) CLINICAL AND MOLECULAR HEPATOLOGY
2013Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir WORLD JOURNAL OF GASTROENTEROLOGY
2019Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells JOURNAL OF HEPATOLOGY
2014Emerging therapies for hepatitis C GUT AND LIVER
2020Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaJOURNAL OF VIRAL HEPATITIS
2014Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2016Entecavir plus tenofovir combination therapy in patients with multidrug-resistant chronic hepatitis B: results of a multicentre, prospective study.LIVER INTERNATIONAL
2020Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response CLINICAL AND MOLECULAR HEPATOLOGY
2022Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mLAMERICAN JOURNAL OF GASTROENTEROLOGY
2020Establishment and Validation of a Risk Prediction Model in Patients With Hepatocellular Carcinoma Treated With Transarterial RadioembolizationEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2005Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization ANTIVIRAL THERAPY
2007Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Browse

Links